Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Times Interest Earned (2017 - 2022)

Historic Times Interest Earned for Sutro Biopharma (STRO) over the last 6 years, with Q3 2022 value amounting to -$7.61.

  • Sutro Biopharma's Times Interest Earned rose 8200.89% to -$7.61 in Q3 2022 from the same period last year, while for Jun 2023 it was -$56.98, marking a year-over-year decrease of 1922.04%. This contributed to the annual value of -$31.41 for FY2021, which is 8020.27% down from last year.
  • Sutro Biopharma's Times Interest Earned amounted to -$7.61 in Q3 2022, which was up 8200.89% from -$32.62 recorded in Q2 2022.
  • Over the past 5 years, Sutro Biopharma's Times Interest Earned peaked at $23.84 during Q2 2018, and registered a low of -$59.56 during Q1 2022.
  • Its 5-year average for Times Interest Earned is -$17.14, with a median of -$12.3 in 2019.
  • Its Times Interest Earned has fluctuated over the past 5 years, first skyrocketed by 16099.83% in 2020, then crashed by 82281.43% in 2021.
  • Quarter analysis of 5 years shows Sutro Biopharma's Times Interest Earned stood at $5.05 in 2018, then tumbled by 458.55% to -$18.09 in 2019, then soared by 161.0% to $11.04 in 2020, then tumbled by 618.72% to -$57.25 in 2021, then soared by 86.71% to -$7.61 in 2022.
  • Its Times Interest Earned was -$7.61 in Q3 2022, compared to -$32.62 in Q2 2022 and -$59.56 in Q1 2022.